The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma	Non-hodgkin Lymphoma,B Cell	Recruiting	Phase 1	2025-11-25		NCT05741359

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bioray Laboratories	10
Chinese Academy of Medical Sciences	36
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319
Zhejiang University	194

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Zhejiang University	Hangzhou	China	4
Tianjin Institute of Hematology	Tianjin	China	1
Wuhan Union Hospital	Wuhan	China	3

Clinical trials